{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:43:30Z","timestamp":1767905010606,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bioorg.2021.104905","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T20:37:05Z","timestamp":1618951025000},"page":"104905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activity"],"prefix":"10.1016","volume":"111","author":[{"given":"Yali","family":"Sang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fener","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.104905_b0005","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.apsb.2019.11.010","article-title":"Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years","volume":"10","author":"Zhuang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2021.104905_b0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cmdc.200800334","article-title":"Structural modifications of DAPY analogues with potent anti-HIV-1 activity","volume":"4","author":"Feng","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2021.104905_b0015","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cclet.2019.11.020","article-title":"Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors","volume":"31","author":"Han","year":"2020","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104905_b0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/acsinfecdis.9b00229","article-title":"Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles","volume":"6","author":"Han","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2021.104905_b0025","doi-asserted-by":"crossref","first-page":"7920","DOI":"10.1021\/jm2010173","article-title":"Design and synthesis of conformationally constrained inhibitors of non-nucleoside reverse transcriptase","volume":"54","author":"Gomez","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104905_b0030","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1039\/C7OB02828H","article-title":"Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored \u201chydrophobic channel\u201d","volume":"16","author":"Zhou","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2021.104905_b0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/COH.0000000000000374","article-title":"Universal antiretroviral regimens: thinking beyond one-pill-once-a-day","volume":"12","author":"Jacobson","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.bioorg.2021.104905_b0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-med-041217-013717","article-title":"Long-Acting HIV Drugs for Treatment and Prevention","volume":"70","author":"Gulick","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bioorg.2021.104905_b0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/COH.0000000000000474","article-title":"Rilpivirine long-acting for the prevention and treatment of HIV infection","volume":"13","author":"Ferretti","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.bioorg.2021.104905_b0050","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1909512","article-title":"Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection","volume":"382","author":"Orkin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2021.104905_b0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.1206399","article-title":"AIDS. Turning the tide against HIV","volume":"333","author":"Shattock","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2021.104905_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2009.10.007","article-title":"Current status and challenges of antiretroviral research and therapy","volume":"85","author":"Este","year":"2010","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.bioorg.2021.104905_b0065","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1021\/acs.jmedchem.8b00843","article-title":"The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic","volume":"62","author":"Namasivayam","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104905_b0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejmech.2018.03.059","article-title":"Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus","volume":"151","author":"Tian","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104905_b0075","doi-asserted-by":"crossref","first-page":"11430","DOI":"10.1021\/acs.jmedchem.9b01446","article-title":"Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles","volume":"62","author":"Sang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104905_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111603","article-title":"Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"182","author":"Sang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104905_b0085","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/cmdc.200900212","article-title":"Design, synthesis, and SAR of naphthyl-substituted Diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase","volume":"4","author":"Liang","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2021.104905_b0090","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1016\/j.bmc.2010.05.036","article-title":"Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors","volume":"18","author":"Liang","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104905_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103595","article-title":"Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase","volume":"96","author":"Sang","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.104905_b0100","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1021\/acs.jmedchem.9b01769","article-title":"Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel","volume":"63","author":"Kang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104905_b0105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ejmech.2018.01.016","article-title":"Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1","volume":"145","author":"Jin","year":"2018","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821002820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821002820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:18:44Z","timestamp":1758615524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821002820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":21,"alternative-id":["S0045206821002820"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104905","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104905"}}